Cargando…
923. Long-term Mortality after Histoplasma Infection in People Living with HIV
BACKGROUND: Histoplasmosis is a common opportunistic infection afflicting people living with HIV (PLWH) globally. There are no data on long term survival of PLWH with histoplasmosis. METHODS: We conducted a single-center retrospective cohort study of PLWH diagnosed with histoplasmosis between 2002 a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776609/ http://dx.doi.org/10.1093/ofid/ofaa439.1110 |
_version_ | 1783630723122462720 |
---|---|
author | Cherabie, Joseph Larson, Lindsey Rutjanawech, Sasinuch Franklin, Alexander Hendrix, Michael J O’Halloran, Jane A Presti, Rachel M Powderly, William Spec, Andrej |
author_facet | Cherabie, Joseph Larson, Lindsey Rutjanawech, Sasinuch Franklin, Alexander Hendrix, Michael J O’Halloran, Jane A Presti, Rachel M Powderly, William Spec, Andrej |
author_sort | Cherabie, Joseph |
collection | PubMed |
description | BACKGROUND: Histoplasmosis is a common opportunistic infection afflicting people living with HIV (PLWH) globally. There are no data on long term survival of PLWH with histoplasmosis. METHODS: We conducted a single-center retrospective cohort study of PLWH diagnosed with histoplasmosis between 2002 and 2017. Data collected included demographics, clinical characteristics, treatment, and mortality. Patients were categorized into three groups based on length of survival after diagnosis: early mortality (death within 90 days), late mortality (death at or after 90 days), and survivors. Between group differences in demographic and clinical characteristics were assessed using Chi square for categorical variables and Mann-Whitney U non-parametric tests for continuous variables. Mortality was compared using Cox proportional hazards. Insurance type (i.e. private versus public option) served as a surrogate indicator of socioeconomic status (SES). Patients diagnosed with histoplasmosis in or after 2008 were considered a part of the modern ART era, regardless of treatment regimen. RESULTS: Our review found 54 PLWH infected with histoplasmosis from 2002-2017. Overall mortality was 37%, with 14.8% early mortality and 22.2% late mortality. Median survival time in the early mortality group was 13.5 days (IQR 2.5-41 days), and 338 days (IQR 180.5-803.3) in the late mortality group. Compared to the late mortality group, survivors were over 6 times more likely to have suppressed HIV viral load at last observation (HR 6.19, p=0.013). Median HIV viral load at last observation was lower among the survivors (2 log copies/ml, IQR 0, 4.5) compared to the late mortality group (4.1 log copies/ml, IQR 2.6,5.5) (p=0.010). Survivors were twice as likely to have private insurance, but this did not reach statistical significance (HR 2.19, p=0.14). There was no statistically significant difference in survival based on the availability of modern ART (p=0.85). The year of diagnosis made no difference with regards to survival (p=0.914). Baseline Characteristics of PLWH with Histoplasmosis [Image: see text] HIV-related Characteristics of PLWH with Histoplasmosis [Image: see text] CONCLUSION: Histoplasmosis continues to be associated with high mortality among PLWH. Improved long-term survival is seen in patients with suppressed HIV viral loads. DISCLOSURES: Andrej Spec, MD, MSCI, Astellas (Grant/Research Support)Mayne (Consultant)Scynexis (Consultant) |
format | Online Article Text |
id | pubmed-7776609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-77766092021-01-07 923. Long-term Mortality after Histoplasma Infection in People Living with HIV Cherabie, Joseph Larson, Lindsey Rutjanawech, Sasinuch Franklin, Alexander Hendrix, Michael J O’Halloran, Jane A Presti, Rachel M Powderly, William Spec, Andrej Open Forum Infect Dis Poster Abstracts BACKGROUND: Histoplasmosis is a common opportunistic infection afflicting people living with HIV (PLWH) globally. There are no data on long term survival of PLWH with histoplasmosis. METHODS: We conducted a single-center retrospective cohort study of PLWH diagnosed with histoplasmosis between 2002 and 2017. Data collected included demographics, clinical characteristics, treatment, and mortality. Patients were categorized into three groups based on length of survival after diagnosis: early mortality (death within 90 days), late mortality (death at or after 90 days), and survivors. Between group differences in demographic and clinical characteristics were assessed using Chi square for categorical variables and Mann-Whitney U non-parametric tests for continuous variables. Mortality was compared using Cox proportional hazards. Insurance type (i.e. private versus public option) served as a surrogate indicator of socioeconomic status (SES). Patients diagnosed with histoplasmosis in or after 2008 were considered a part of the modern ART era, regardless of treatment regimen. RESULTS: Our review found 54 PLWH infected with histoplasmosis from 2002-2017. Overall mortality was 37%, with 14.8% early mortality and 22.2% late mortality. Median survival time in the early mortality group was 13.5 days (IQR 2.5-41 days), and 338 days (IQR 180.5-803.3) in the late mortality group. Compared to the late mortality group, survivors were over 6 times more likely to have suppressed HIV viral load at last observation (HR 6.19, p=0.013). Median HIV viral load at last observation was lower among the survivors (2 log copies/ml, IQR 0, 4.5) compared to the late mortality group (4.1 log copies/ml, IQR 2.6,5.5) (p=0.010). Survivors were twice as likely to have private insurance, but this did not reach statistical significance (HR 2.19, p=0.14). There was no statistically significant difference in survival based on the availability of modern ART (p=0.85). The year of diagnosis made no difference with regards to survival (p=0.914). Baseline Characteristics of PLWH with Histoplasmosis [Image: see text] HIV-related Characteristics of PLWH with Histoplasmosis [Image: see text] CONCLUSION: Histoplasmosis continues to be associated with high mortality among PLWH. Improved long-term survival is seen in patients with suppressed HIV viral loads. DISCLOSURES: Andrej Spec, MD, MSCI, Astellas (Grant/Research Support)Mayne (Consultant)Scynexis (Consultant) Oxford University Press 2020-12-31 /pmc/articles/PMC7776609/ http://dx.doi.org/10.1093/ofid/ofaa439.1110 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Abstracts Cherabie, Joseph Larson, Lindsey Rutjanawech, Sasinuch Franklin, Alexander Hendrix, Michael J O’Halloran, Jane A Presti, Rachel M Powderly, William Spec, Andrej 923. Long-term Mortality after Histoplasma Infection in People Living with HIV |
title | 923. Long-term Mortality after Histoplasma Infection in People Living with HIV |
title_full | 923. Long-term Mortality after Histoplasma Infection in People Living with HIV |
title_fullStr | 923. Long-term Mortality after Histoplasma Infection in People Living with HIV |
title_full_unstemmed | 923. Long-term Mortality after Histoplasma Infection in People Living with HIV |
title_short | 923. Long-term Mortality after Histoplasma Infection in People Living with HIV |
title_sort | 923. long-term mortality after histoplasma infection in people living with hiv |
topic | Poster Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776609/ http://dx.doi.org/10.1093/ofid/ofaa439.1110 |
work_keys_str_mv | AT cherabiejoseph 923longtermmortalityafterhistoplasmainfectioninpeoplelivingwithhiv AT larsonlindsey 923longtermmortalityafterhistoplasmainfectioninpeoplelivingwithhiv AT rutjanawechsasinuch 923longtermmortalityafterhistoplasmainfectioninpeoplelivingwithhiv AT franklinalexander 923longtermmortalityafterhistoplasmainfectioninpeoplelivingwithhiv AT hendrixmichaelj 923longtermmortalityafterhistoplasmainfectioninpeoplelivingwithhiv AT ohalloranjanea 923longtermmortalityafterhistoplasmainfectioninpeoplelivingwithhiv AT prestirachelm 923longtermmortalityafterhistoplasmainfectioninpeoplelivingwithhiv AT powderlywilliam 923longtermmortalityafterhistoplasmainfectioninpeoplelivingwithhiv AT specandrej 923longtermmortalityafterhistoplasmainfectioninpeoplelivingwithhiv |